Optimising acid inhibition treatment

Fernando Gomollón, Xavier Calvet

Research output: Contribution to journalReview articleResearchpeer-review

6 Citations (Scopus)

Abstract

Acid inhibition is safe and useful in several clinical settings. Proton pump inhibitors are more effective than H2-receptor antagonists in virtually all cases. Proton pump inhibitors should be used in: the eradication of Helicobacter pylori; the treatment of non-H. pylori-related peptic ulcer healing; for the prevention and treatment of non-steroidal anti-inflammatory drug-induced upper digestive lesions; for bleeding peptic lesions; and, especially, in the short-term and long-term control of gastro-oesophageal reflux disease. The timing, the dosing and the specific drugs should be adapted to the particular patient, clinical situation and local factors. For instance, in a patient with active bleeding from a duodenal ulcer, intravenous constant infusion should be the preferred treatment. When seeking oral 'potent' acid inhibition (refractory gastrooesophageal reflux disease, and perhaps Barrett's oesophagus), available data suggest that the pharmacological and clinical profiles of esomeprazole are slightly better. © Adis Data Information BV 2005. All rights reserved.
Original languageEnglish
Pages (from-to)25-33
JournalDrugs
Volume65
Issue numberSUPPL. 1
Publication statusPublished - 1 Dec 2005

Fingerprint Dive into the research topics of 'Optimising acid inhibition treatment'. Together they form a unique fingerprint.

Cite this